Among patients with an infection ratio lower than 9.2, the mortality rate in the nirmatrelvir/ritonavir group was lower than in the azvudine group, but it did not reach statistical significance due to wide confidence intervals.
← all excerpts
Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID-19 Patients Receiving Antivirals.
1
—
—